Ehninger G - Search Results

1

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.

Krug U, Röllig C, Koschmieder A, Heinecke A, Sauerland MC, Schaich M, Thiede C, Kramer M, Braess J, Spiekermann K, Haferlach T, Haferlach C, Koschmieder S, Rohde C, Serve H, Wörmann B, Hiddemann W, Ehninger G, Berdel WE, Büchner T, Müller-Tidow C; German Acute Myeloid Leukaemia Cooperative Group; Study Alliance Leukemia Investigators. Krug U, et al. Among authors: ehninger g. Lancet. 2010 Dec 11;376(9757):2000-8. doi: 10.1016/S0140-6736(10)62105-8. Epub 2010 Dec 3. Lancet. 2010. PMID: 21131036

2

Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.

Schetelig J, Kröger N, Held TK, Thiede C, Krusch A, Zabelina T, Dubiel M, Rick O, Bornhäuser M, Ehninger G, Zander AR, Siegert W. Schetelig J, et al. Among authors: ehninger g. Haematologica. 2002 Mar;87(3):299-305. Haematologica. 2002. PMID: 11869943

3

Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.

Schaich M, Harbich-Brutscher E, Pascheberg U, Mohr B, Soucek S, Ehninger G, Illmer T. Schaich M, et al. Among authors: ehninger g. Haematologica. 2002 May;87(5):455-64. Haematologica. 2002. PMID: 12010657

4

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

Thiede C, Steudel C, Mohr B, Schaich M, Schäkel U, Platzbecker U, Wermke M, Bornhäuser M, Ritter M, Neubauer A, Ehninger G, Illmer T. Thiede C, et al. Among authors: ehninger g. Blood. 2002 Jun 15;99(12):4326-35. doi: 10.1182/blood.v99.12.4326. Blood. 2002. PMID: 12036858 Free article.

5

Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.

Schaich M, Illmer T, Aulitzky W, Bodenstein H, Clemens M, Neubauer A, Repp R, Schäkel U, Soucek S, Wandt H, Ehninger G; SHG AML96 Study Group. Schaich M, et al. Among authors: ehninger g. Haematologica. 2002 Aug;87(8):808-15. Haematologica. 2002. PMID: 12161356 Clinical Trial.

6

MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.

Illmer T, Schuler US, Thiede C, Schwarz UI, Kim RB, Gotthard S, Freund D, Schäkel U, Ehninger G, Schaich M. Illmer T, et al. Among authors: ehninger g. Cancer Res. 2002 Sep 1;62(17):4955-62. Cancer Res. 2002. PMID: 12208746

7

Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia.

Kreuzer KA, Schmidt CA, Schetelig J, Held TK, Thiede C, Ehninger G, Siegert W. Kreuzer KA, et al. Among authors: ehninger g. Eur J Haematol. 2002 Jul;69(1):7-10. doi: 10.1034/j.1600-0609.2002.01761.x. Eur J Haematol. 2002. PMID: 12270056

8

Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studies.

Büchner T, Döhner H, Ehninger G, Ganser A, Hasford J; German AML Inter-group. Büchner T, et al. Among authors: ehninger g. Leuk Res. 2002 Dec;26(12):1073-5. doi: 10.1016/s0145-2126(02)00084-x. Leuk Res. 2002. PMID: 12443878

9

Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.

Steudel C, Wermke M, Schaich M, Schäkel U, Illmer T, Ehninger G, Thiede C. Steudel C, et al. Among authors: ehninger g. Genes Chromosomes Cancer. 2003 Jul;37(3):237-51. doi: 10.1002/gcc.10219. Genes Chromosomes Cancer. 2003. PMID: 12759922

10

Mixed response after allogeneic haemopoietic-cell transplantation for metastatic renal-cell carcinoma.

Bornhäuser M, Klenk U, Röllig C, Haack M, Babatz J, Koch O, Baretton G, Ehninger G. Bornhäuser M, et al. Among authors: ehninger g. Lancet Oncol. 2004 Mar;5(3):191-2. doi: 10.1016/S1470-2045(04)01415-9. Lancet Oncol. 2004. PMID: 15003203 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

815 results

Search Page

Filters